KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 71 filers reported holding KALEIDO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $32,300,000 | -31.0% | 19,575,710 | 0.0% | 0.76% | +4.8% |
| Q4 2021 | $46,787,000 | -56.2% | 19,575,710 | 0.0% | 0.72% | -35.4% |
| Q3 2021 | $106,883,000 | -26.6% | 19,575,710 | 0.0% | 1.12% | -39.8% |
| Q2 2021 | $145,643,000 | -8.1% | 19,575,710 | 0.0% | 1.86% | -26.7% |
| Q1 2021 | $158,562,000 | -10.0% | 19,575,710 | +1.1% | 2.54% | -20.8% |
| Q4 2020 | $176,183,000 | -17.8% | 19,360,710 | 0.0% | 3.21% | -45.8% |
| Q3 2020 | $214,323,000 | +49.0% | 19,360,710 | 0.0% | 5.92% | +41.7% |
| Q2 2020 | $143,851,000 | +34.7% | 19,360,710 | +11.5% | 4.18% | -16.5% |
| Q1 2020 | $106,768,000 | +22.5% | 17,360,710 | 0.0% | 5.00% | +2.7% |
| Q4 2019 | $87,151,000 | -33.3% | 17,360,710 | 0.0% | 4.87% | -31.9% |
| Q3 2019 | $130,727,000 | -35.1% | 17,360,710 | 0.0% | 7.15% | -18.0% |
| Q2 2019 | $201,385,000 | -20.0% | 17,360,710 | 0.0% | 8.72% | -8.5% |
| Q1 2019 | $251,731,000 | – | 17,360,710 | – | 9.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 1,833,832 | $16,688,000 | 6.52% |
| Flagship Pioneering Inc. | 19,360,710 | $176,183,000 | 3.21% |
| Trustees of Columbia University in the City of New York | 150,150 | $1,366,000 | 1.82% |
| Palo Alto Investors LP | 786,400 | $7,156,000 | 0.38% |
| Artal Group S.A. | 500,500 | $4,555,000 | 0.10% |
| BAINCO INTERNATIONAL INVESTORS | 14,500 | $132,000 | 0.02% |
| FEDERATED HERMES, INC. | 500,000 | $4,550,000 | 0.01% |
| Johnson Midwest Financial, LLC | 745 | $7,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 24,398 | $222,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,071 | $92,000 | 0.00% |